ENX-104

DRUG3 trials

Sponsors

Engrail Therapeutics INC

Conditions

Healthy VolunteersMajor Depressive Disorder

Phase 1

ENX-104 MAD Study for Participants With Major Depressive Disorder With Anhedonia (aMDD)

CompletedNCT07253324

Engrail Therapeutics INCMajor Depressive Disorder

Start: 2025-02-17End: 2025-11-26Updated: 2025-12-31

A PET Study of ENX-104 in Healthy Volunteers

CompletedNCT07253272

Engrail Therapeutics INCHealthy Volunteers

Start: 2025-02-24End: 2025-09-02Updated: 2025-11-28

A Study of ENX-104 in Healthy Participants

CompletedNCT07472361

Engrail Therapeutics INCHealthy Volunteers

Start: 2026-02-25End: 2026-03-19Updated: 2026-04-22